Evidence map›Paper›PMID 42493506›Full record

ArticleNature communications2026

HELZ-BRCA2 complex resolves R-loops to drive transcription-coupled homologous recombination.

Wenjing Li, Bo Wu, Boya Gao, Elizabeth M Irvin, Arijit Ghosh, Lillian Eliaz, Yuxin Huang, Youngho Kwon, Clara M Stiefel, Tram Thi Ngoc Nguyen and 16 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Wenjing Li *Department of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0001-9151-9219
Bo Wu *Department of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0009-0009-1610-3892
Boya GaoDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA.
Elizabeth M IrvinDepartment of Physics, Center for Human Health and the Environment, Toxicology Program, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0001-8274-7113
Arijit GhoshDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA.
Lillian EliazDepartment of Chemistry & Biochemistry Materials Science, Engineering, and Commercialization Program, Integrated Molecular and Biophysical Chemistry Program, Texas State University, San Marcos, TX, USA.ORCID 0009-0000-4364-8075
Yuxin HuangDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Youngho KwonDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0002-0287-8795
Clara M StiefelDepartment of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Tram Thi Ngoc NguyenDepartment of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0002-0400-1663
David ZhaoDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Humberto Javier SuarezDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Tengyang NiDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Salvador AlejoDepartment of Obstetrics & Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0002-1390-9892
O'Taveon FitzgeraldDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Xuemei SongDepartment of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Sandip Kumar RathDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Elizabeth V WasmuthDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
David S YuDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Siyuan ZhengDepartment of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0002-1031-9424
Justin LeungDepartment of Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.ORCID 0000-0003-4601-390X
Xiaoyu XueDepartment of Chemistry & Biochemistry Materials Science, Engineering, and Commercialization Program, Integrated Molecular and Biophysical Chemistry Program, Texas State University, San Marcos, TX, USA.ORCID 0000-0001-9654-6566
Hong WangDepartment of Physics, Center for Human Health and the Environment, Toxicology Program, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0003-0165-3559
Jae-Hoon JiDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. jij@uthscsa.edu.ORCID 0009-0001-8233-9416
Li LanDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA. li.lan@duke.edu.ORCID 0000-0003-0383-6172
Weixing ZhaoDepartment of Biochemistry and Structural Biology, Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. zhaow2@uthscsa.edu.ORCID 0000-0001-5746-3696

Funding

Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Sue Fenton · 2015 to 2026
$18.3M
Regulation of BRCA-dependent Genome Repair via the 53BP1 AxisP01CA275717 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robert A Hromas · 2024 to 2026
$10.1M
Defining the role of BARD1 in nucleosomal ubiquitylationR01CA260834 · NCI · UNIVERSITY OF WASHINGTON · PI BRZOVIC, PETER S, KLEVIT, RACHEL E · 2021 to 2025
$2.7M
Deciphering the chromatin-based DNA damage response pathwayR35GM137798 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Justin Wai Chung Leung · 2020 to 2026
$2.4M
Genome Maintenance via the BRCA-RAD54 Axis.R01GM141091 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHAO, WEIXING WILSON · 2021 to 2025
$1.8M
Mechanistic characterization of the cell cycle-dependent DNA repair pathway- ResubmissionR01CA244261 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI Justin Wai Chung Leung · 2021 to 2026
$1.5M
Understanding and Targeting the R-Loop-Mediated DNA Damage Response at TelomeresR01CA282939 · NCI · DUKE UNIVERSITY · PI Li Lan · 2023 to 2026
$1.5M
Biochemical, structural and molecular dissection of androgen receptor transcriptional activity.R00GM140264 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI WASMUTH, ELIZABETH VICTORINA · 2022 to 2024
$835k
BRCA-dependent Mechanisms of Genome Maintenance and RepairR50CA265315 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI YOUNGHO KWON · 2022 to 2026
$818k
Roles of the human UAP56 helicase in co-transcriptional R-loop resolution and genome maintenanceR15GM139135 · NIGMS · TEXAS STATE UNIVERSITY · PI XUE, XIAOYU · 2020 to 2020
$436k
Deciphering the function of cohesin and CTCF in R-loop-mediated DNA repair at telomeresF31AG092149 · NIA · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Elizabeth Marie Irvin · 2025 to 2026
$84k
American Cancer Society (American Cancer Society, Inc.) DBG-25-1292405-01-DMCAmerican Cancer Society (American Cancer Society, Inc.) RSG-22-721675-01-DMCCancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP210102Max and Minnie Tomerlin Voelcker Fund (Voelcker Fund) a Young Investigator AwardNCI NIH HHS P01 CA275717NCI NIH HHS R01 CA244261NCI NIH HHS R01 CA260834NCI NIH HHS R01 CA282939NCI NIH HHS R50 CA265315NIA NIH HHS F31 AG092149NIEHS NIH HHS P30 ES025128NIGMS NIH HHS R00 GM140264NIGMS NIH HHS R01 GM141091NIGMS NIH HHS R15 GM139135NIGMS NIH HHS R35 GM137798U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P01CA275717U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM141091
6 · The paper itself

Abstract

R-loops are transcription-induced, three-stranded nucleic acid structures that, if not properly resolved, can disrupt DNA repair and compromise genome stability. BRCA2, a tumor suppressor vital for homologous recombination (HR), also contributes to R-loop regulation, though the underlying mechanisms remain poorly understood. Here, we identify HELZ as a direct BRCA2 interactor and characterize it as an ssRNA-specific R-loop resolvase. BRCA2 enhances HELZ helicase activity and promotes its recruitment to R-loops. Importantly, HELZ resolves R-loops at DNA double-strand breaks, enabling efficient DNA end resection and HR, particularly within transcriptionally active genomic regions. We further demonstrate that HELZ is critical for R-loop clearance in cancers with elevated transcriptional activity and R-loop accumulation, such as estrogen receptor-positive breast cancer, where it becomes essential for cell survival under estrogen-induced transcriptional stress. These findings establish HELZ as a BRCA2-dependent regulator of R-loop homeostasis and identify it as a potential biomarker and therapeutic target in R-loop-driven malignancies.

Indexed as

BRCA2 ProteinDNA HelicasesHomologous RecombinationR-Loop StructuresTranscription, GeneticBreast NeoplasmsCell Line, TumorDNA Breaks, Double-StrandedHumansBRCA2 ProteinBRCA2 protein, humanDNA Helicases

Identifiers

PMID42493506
PMCPMC13396364

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.